Glutarate

Glutarate

SCHEMBL2449984

NCCN.O=C(O)CCCC(=O)O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glutarate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.77
TSHR P16473 3/20 0.77
THRB P10828 2/20 0.77
BLM P54132 2/20 0.77
KMT2A Q03164 2/20 0.77
NPSR1 Q6W5P4 2/20 0.77
GABRR1 P24046 2/20 0.77
GABRR3 A8MPY1 1/20 0.77
GABRP O00591 1/20 0.77
GABRD O14764 1/20 0.77
HDAC3 O15379 1/20 0.77
GABBR2 O75899 1/20 0.77
CYP1A2 P05177 1/20 0.77
GABRA1 P14867 1/20 0.77
GABRB1 P18505 1/20 0.77
GABRG2 P18507 1/20 0.77
GABRB3 P28472 1/20 0.77
GABRR2 P28476 1/20 0.77
SLC6A1 P30531 1/20 0.77
GABRA5 P31644 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutarate SCHEMBL143588 1.00 LMNA (0.77) LMNATSHRTHRBBLMKMT2A
Glutarate SCHEMBL6815061 0.97 LMNA (0.72) LMNATSHRTHRBBLMKMT2A
Glutarate SCHEMBL28335483 0.97 LMNA (0.72) LMNATSHRTHRBBLMKMT2A
Adipic Acid SCHEMBL11328398 0.93 NFKB1 (0.82) LMNATSHRTHRBBLMKMT2A
Adipic Acid SCHEMBL9133305 0.93 NFKB1 (0.82) LMNATSHRTHRBBLMKMT2A
Adipic Acid SCHEMBL1647321 0.93 NFKB1 (0.82) LMNATSHRTHRBBLMKMT2A
Glutarate SCHEMBL9453439 0.90 LMNA (0.82) LMNATSHRTHRBBLMKMT2A
Glutarate SCHEMBL2915734 0.90 LMNA (0.82) LMNATSHRTHRBBLMKMT2A
Azelaic Acid SCHEMBL11141213 0.90 LMNA (0.83) LMNATSHRTHRBBLMKMT2A
Octanedioate SCHEMBL11875945 0.90 LMNA (0.83) LMNATSHRTHRBBLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111303122-A Pomalidomide derivative and application thereof 南方医科大学 2020-06-19 CN claimed
CN-105772979-A High flux environment-friendly tin wire and preparation method thereof 苏州伊飞特电子科技有限公司 2016-07-20 CN claimed
CN-115812001-A Azoxystrobin in sulfate-free personal care compositions 宝洁公司 2023-03-17 CN disclosed
CN-115151310-A Sulfur-containing anti-dandruff compositions with enhanced efficacy and aesthetics 宝洁公司 2022-10-04 CN disclosed
CN-111303122-A Pomalidomide derivative and application thereof 南方医科大学 2020-06-19 CN disclosed
CN-111303122-A Pomalidomide derivative and application thereof 南方医科大学 2020-06-19 CN disclosed
CN-105772979-A High flux environment-friendly tin wire and preparation method thereof 苏州伊飞特电子科技有限公司 2016-07-20 CN disclosed
EP-1546297-B1 HIGH CONCENTRATION SURFACTANT COMPOSITIONS AND METHODS RHODIA OPERATIONS (FR) 2011-09-28 EP disclosed
US-7449435-B2 High concentration surfactant compositions and methods MCINTYRE GROUP, LTD. (US) 2008-11-11 US disclosed
US-20070270326-A1 High concentration surfactant compositions and methods MCINTYRE GROUP, LTD. 2007-11-22 US disclosed
US-7256164-B2 High concentration surfactant compositions and methods MCINTYRE GROUP, LTD. (US) 2007-08-14 US disclosed
EP-1546297-A4 HIGH CONCENTRATION SURFACTANT COMPOSITIONS AND METHODS MCINTYRE GROUP LTD (US) 2006-06-07 EP disclosed
EP-1546297-A2 HIGH CONCENTRATION SURFACTANT COMPOSITIONS AND METHODS McINTYRE GROUP, LTD. (US) 2005-06-29 EP disclosed
US-20050037942-A1 High concentration surfactant compositions and methods RHODIA OPERATIONS (FR) 2005-02-17 US disclosed
WO-2004015047-A2 HIGH CONCENTRATION SURFACTANT COMPOSITIONS AND METHODS MCINTYRE GROUP, LTD. (US) 2004-02-19 WO disclosed